Bay w 9798, a dihydropyridine structurally related to nifedipine with no calcium channel-blocking properties, inhibits tumour necrosis factor-α-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation

T. Matsui, Sho Ichi Yamagishi, K. Nakamura, Hiroyoshi Inoue

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Dihydropyridine-based calcium antagonists (DHPs) are widely used to treat hypertension. We have previously shown that nifedipine, one of the most popular DHPs, blocks tumour necrosis factor-α (TNF-α)-induced monocyte chemoattractant protein-1 as well as vascular cell adhesion molecule-1 (VCAM-1) expression in endothelial cells by suppressing reactive oxygen species generation (ROS). The molecular mechanism is still to be elucidated, however, because endothelial cells do not possess voltage-operated L-type calcium channels. The aim of this study was to determine in TNF-α-exposed human umbilical vein endothelial cells (HUVECs) whether and how Bay w 9798, a dihydropyridine structurally related to nifedipine with no calcium antagonistic properties, may suppress VCAM-1 expression, a key molecule which mediates the adhesion of monocytes to vasculature in the early stages of atherosclerosis. In HUVECs, 10 ng/ml TNF-α for 4 h stimulated ROS generation and subsequently upregulated VCAM-1 mRNA levels, both of which were dose-dependently blocked by Bay w 9798. The results demonstrated that Bay w 9798 inhibited VCAM-1 expression in TNF-α-exposed cells by suppressing ROS generation. They suggest that the anti-inflammatory and anti-oxidative properties of nifedipine and Bay w 9798 may be ascribed to the dihydropyridine structure, which is common to both molecules and has no calcium antagonistic ability.

Original languageEnglish
Pages (from-to)886-891
Number of pages6
JournalJournal of International Medical Research
Volume35
Issue number6
Publication statusPublished - 2007 Nov
Externally publishedYes

Fingerprint

Vascular Cell Adhesion Molecule-1
Endothelial cells
Calcium Channels
Nifedipine
Reactive Oxygen Species
Endothelial Cells
Tumor Necrosis Factor-alpha
Human Umbilical Vein Endothelial Cells
Calcium
L-Type Calcium Channels
Molecules
Chemokine CCL2
Monocytes
Atherosclerosis
Anti-Inflammatory Agents
Adhesion
Hypertension
Messenger RNA
1,4-dihydropyridine
Bay w 9798

Keywords

  • Atherosclerosis
  • Bay w 9798
  • Dihydropyridines
  • Human umbilical vein endothelial cells (HUVECs)
  • Nifedipine
  • Oxidative stress
  • Tumour necrosis factor-α (TNF-α)
  • Vascular cell adhesion molecule-1 (VCAM-1)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{420cb7590f224ccbaeeb2d3a19065162,
title = "Bay w 9798, a dihydropyridine structurally related to nifedipine with no calcium channel-blocking properties, inhibits tumour necrosis factor-α-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation",
abstract = "Dihydropyridine-based calcium antagonists (DHPs) are widely used to treat hypertension. We have previously shown that nifedipine, one of the most popular DHPs, blocks tumour necrosis factor-α (TNF-α)-induced monocyte chemoattractant protein-1 as well as vascular cell adhesion molecule-1 (VCAM-1) expression in endothelial cells by suppressing reactive oxygen species generation (ROS). The molecular mechanism is still to be elucidated, however, because endothelial cells do not possess voltage-operated L-type calcium channels. The aim of this study was to determine in TNF-α-exposed human umbilical vein endothelial cells (HUVECs) whether and how Bay w 9798, a dihydropyridine structurally related to nifedipine with no calcium antagonistic properties, may suppress VCAM-1 expression, a key molecule which mediates the adhesion of monocytes to vasculature in the early stages of atherosclerosis. In HUVECs, 10 ng/ml TNF-α for 4 h stimulated ROS generation and subsequently upregulated VCAM-1 mRNA levels, both of which were dose-dependently blocked by Bay w 9798. The results demonstrated that Bay w 9798 inhibited VCAM-1 expression in TNF-α-exposed cells by suppressing ROS generation. They suggest that the anti-inflammatory and anti-oxidative properties of nifedipine and Bay w 9798 may be ascribed to the dihydropyridine structure, which is common to both molecules and has no calcium antagonistic ability.",
keywords = "Atherosclerosis, Bay w 9798, Dihydropyridines, Human umbilical vein endothelial cells (HUVECs), Nifedipine, Oxidative stress, Tumour necrosis factor-α (TNF-α), Vascular cell adhesion molecule-1 (VCAM-1)",
author = "T. Matsui and Yamagishi, {Sho Ichi} and K. Nakamura and Hiroyoshi Inoue",
year = "2007",
month = "11",
language = "English",
volume = "35",
pages = "886--891",
journal = "Journal of International Medical Research",
issn = "0300-0605",
publisher = "Field House Publishing LLP",
number = "6",

}

TY - JOUR

T1 - Bay w 9798, a dihydropyridine structurally related to nifedipine with no calcium channel-blocking properties, inhibits tumour necrosis factor-α-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation

AU - Matsui, T.

AU - Yamagishi, Sho Ichi

AU - Nakamura, K.

AU - Inoue, Hiroyoshi

PY - 2007/11

Y1 - 2007/11

N2 - Dihydropyridine-based calcium antagonists (DHPs) are widely used to treat hypertension. We have previously shown that nifedipine, one of the most popular DHPs, blocks tumour necrosis factor-α (TNF-α)-induced monocyte chemoattractant protein-1 as well as vascular cell adhesion molecule-1 (VCAM-1) expression in endothelial cells by suppressing reactive oxygen species generation (ROS). The molecular mechanism is still to be elucidated, however, because endothelial cells do not possess voltage-operated L-type calcium channels. The aim of this study was to determine in TNF-α-exposed human umbilical vein endothelial cells (HUVECs) whether and how Bay w 9798, a dihydropyridine structurally related to nifedipine with no calcium antagonistic properties, may suppress VCAM-1 expression, a key molecule which mediates the adhesion of monocytes to vasculature in the early stages of atherosclerosis. In HUVECs, 10 ng/ml TNF-α for 4 h stimulated ROS generation and subsequently upregulated VCAM-1 mRNA levels, both of which were dose-dependently blocked by Bay w 9798. The results demonstrated that Bay w 9798 inhibited VCAM-1 expression in TNF-α-exposed cells by suppressing ROS generation. They suggest that the anti-inflammatory and anti-oxidative properties of nifedipine and Bay w 9798 may be ascribed to the dihydropyridine structure, which is common to both molecules and has no calcium antagonistic ability.

AB - Dihydropyridine-based calcium antagonists (DHPs) are widely used to treat hypertension. We have previously shown that nifedipine, one of the most popular DHPs, blocks tumour necrosis factor-α (TNF-α)-induced monocyte chemoattractant protein-1 as well as vascular cell adhesion molecule-1 (VCAM-1) expression in endothelial cells by suppressing reactive oxygen species generation (ROS). The molecular mechanism is still to be elucidated, however, because endothelial cells do not possess voltage-operated L-type calcium channels. The aim of this study was to determine in TNF-α-exposed human umbilical vein endothelial cells (HUVECs) whether and how Bay w 9798, a dihydropyridine structurally related to nifedipine with no calcium antagonistic properties, may suppress VCAM-1 expression, a key molecule which mediates the adhesion of monocytes to vasculature in the early stages of atherosclerosis. In HUVECs, 10 ng/ml TNF-α for 4 h stimulated ROS generation and subsequently upregulated VCAM-1 mRNA levels, both of which were dose-dependently blocked by Bay w 9798. The results demonstrated that Bay w 9798 inhibited VCAM-1 expression in TNF-α-exposed cells by suppressing ROS generation. They suggest that the anti-inflammatory and anti-oxidative properties of nifedipine and Bay w 9798 may be ascribed to the dihydropyridine structure, which is common to both molecules and has no calcium antagonistic ability.

KW - Atherosclerosis

KW - Bay w 9798

KW - Dihydropyridines

KW - Human umbilical vein endothelial cells (HUVECs)

KW - Nifedipine

KW - Oxidative stress

KW - Tumour necrosis factor-α (TNF-α)

KW - Vascular cell adhesion molecule-1 (VCAM-1)

UR - http://www.scopus.com/inward/record.url?scp=36949040856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36949040856&partnerID=8YFLogxK

M3 - Article

C2 - 18084847

AN - SCOPUS:36949040856

VL - 35

SP - 886

EP - 891

JO - Journal of International Medical Research

JF - Journal of International Medical Research

SN - 0300-0605

IS - 6

ER -